Grey matter atrophy in MS. Is it a solution for clinico-radiological paradox?

The correlation between clinical symptoms and traditional MRI biomarkers in multiple sclerosis is modest. The lesion burden is only a weak predictor of long term outcome of the disease. In this webinar we will investigate if brain atrophy could be used as a biomarker of the disease that can resolve the clinico-radiological paradox and predict the outcome.